Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer
COVID-19: One in three infected, unvaccinated people no longer have detectable antibodies one year after infection
16 September 2022Most LGBTQI+ cancer patients lack resources tailored to gender/sexual identity
16 September 2022Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer
Black women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women if treated at an earlier disease stage but less likely to benefit than white women if treated at a later disease stage, according to results presented at the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 16-19, 2022.
